(a)
(b)
(c)

Figure 2: (a) Surgically removed textured silicone implant. (b) Fibrous capsule from which the implant was removed; solid BIA-ALCL deposits on the internal surface; (c) seroma fluid from inside the fibrous capsule which contained CD30-positive atypical lymphocytes.